Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars 
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
MIGDAL HA'EMEQ, Israel, May 25, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today announced that Mr. Erez Israeli, the Company’s Chief Executive Officer, will present at the Jefferies 2017 Global Healthcare Conference being held on June 6-9, 2017 at the Grand Hyatt New York in New York City.
Mr. Israeli is scheduled to present on Thursday, June 8, 2017 at 4:30 PM EDT. The presentation will take place in 7 Imperial. The presentation will be followed immediately by a breakout session at 5:00 PM EDT in the Booth Room.
Mr. Israeli and Mr. Oren Bryan, the Company’s Chief Financial Officer, will also be available to participate in one-to-one meetings with investors during the conference.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.
Contact The Ruth Group Tram Bui / Alexander Lobo Phone: 646-536-7035 / 7037 [email protected] [email protected]
